Eun Young Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eun Young Jeong has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jae-Woong Jeong
School of Electrical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
2 shared publications Sungwoo Cho
Korea Advanced Institute of Science and Technology
2 shared publications- Anisha Reimert
University of California, Los Angeles
1 shared publication - Catherine M. Cahill
University of California, Los Angeles
1 shared publication - Choong Yeon Kim
School of Electrical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
1 shared publication - Collin D. Teague
Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA
1 shared publication
Latest Publications
- Open Access
A Wireless Wearable Platform for Intravenous Drug Self-Administration in Freely Behaving Rats
Studying how drugs act on neuronal circuits requires delivering them with temporal precision while behavior proceeds undisturbed, a combination that tethered infusion systems cannot provide. We developed WEARIT (Wireless Equipment for Autonomous Rat Infusion Tasks), a wearable, tetherless infusion platform that gives freely moving rats intravenous access under either remote or closed-loop operant control. The device houses a reservoir, miniaturized pump, rechargeable battery and Bluetooth circuitry in a 3D–printed enclosure worn on the back. By measuring spontaneous locomotion, amphetamine–induced hyperlocomotion and food–reinforced operant responding, we show that WEARIT leaves these behaviors unchanged. Remotely triggered fentanyl infusions yielded reliable delivery with physiological responses confirmed by pulse oximetry, and self-administration acquisition and dose–response functions were comparable to conventional tethered systems. WEARIT removes a longstanding constraint on intravenous pharmacology, opening self-administration paradigms to naturalistic and enriched environments and to concurrent imaging or optogenetic manipulation of the circuits engaged by drug reinforcement.
Open AccessA Wireless Wearable Platform for Intravenous Drug Self-Administration in Freely Behaving Rats
Studying how drugs act on neuronal circuits requires delivering them with temporal precision while behavior proceeds undisturbed, a combination that tethered infusion systems cannot provide. We developed WEARIT (Wireless Equipment for Autonomous Rat Infusion Tasks), a wearable, tetherless infusion platform that gives freely moving rats intravenous access under either remote or closed-loop operant control. The device houses a reservoir, miniaturized pump, rechargeable battery and Bluetooth circuitry in a 3D–printed enclosure worn on the back. By measuring spontaneous locomotion, amphetamine–induced hyperlocomotion and food–reinforced operant responding, we show that WEARIT leaves these behaviors unchanged. Remotely triggered fentanyl infusions yielded reliable delivery with physiological responses confirmed by pulse oximetry, and self-administration acquisition and dose–response functions were comparable to conventional tethered systems. WEARIT removes a longstanding constraint on intravenous pharmacology, opening self-administration paradigms to naturalistic and enriched environments and to concurrent imaging or optogenetic manipulation of the circuits engaged by drug reinforcement.
- Open Access
- 31 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (31) , eaee8648
IoT-enabled wireless neural implant for chronic, programmable neuropharmacology and optogenetics
Wireless in vivo neuropharmacology and optogenetics offer a powerful way to link molecular signaling, defined neural populations, and behavior in freely moving animals. However, existing implantable wireless systems developed for this purpose often suffer from imprecise dosing, backflow contamination, and nonrefillable reservoirs, and their reliance on experimenter presence can itself alter neural activity and behavior. Here, we introduce a remotely actuated and programmable implant for drug delivery and optical stimulation (RAPIDO), which integrates a refillable, replaceable, and backflow-free fluidic module with a microscale inorganic light-emitting diode probe in a single miniaturized implant. A replaceable cartridge with an integrated unidirectional valve enables rapid refilling with contamination-free dosing, while a programmable electrochemical pump provides multilevel flow-rate control and linear dose modulation. Dual wireless modes combine smartphone control for on-site interactive experiments with internet connectivity for remotely scheduled, observer-free operation. In freely behaving rodents, RAPIDO enabled repeated wireless pharmacological modulation of locomotor behavior and independent optogenetic manipulation of intracellular signaling during cocaine conditioning. This platform establishes a foundation for chronic multimodal neuromodulation, supporting long-term circuit studies across distributed laboratories.
- 31 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (31) , eaee8648
Open AccessIoT-enabled wireless neural implant for chronic, programmable neuropharmacology and optogenetics
Wireless in vivo neuropharmacology and optogenetics offer a powerful way to link molecular signaling, defined neural populations, and behavior in freely moving animals. However, existing implantable wireless systems developed for this purpose often suffer from imprecise dosing, backflow contamination, and nonrefillable reservoirs, and their reliance on experimenter presence can itself alter neural activity and behavior. Here, we introduce a remotely actuated and programmable implant for drug delivery and optical stimulation (RAPIDO), which integrates a refillable, replaceable, and backflow-free fluidic module with a microscale inorganic light-emitting diode probe in a single miniaturized implant. A replaceable cartridge with an integrated unidirectional valve enables rapid refilling with contamination-free dosing, while a programmable electrochemical pump provides multilevel flow-rate control and linear dose modulation. Dual wireless modes combine smartphone control for on-site interactive experiments with internet connectivity for remotely scheduled, observer-free operation. In freely behaving rodents, RAPIDO enabled repeated wireless pharmacological modulation of locomotor behavior and independent optogenetic manipulation of intracellular signaling during cocaine conditioning. This platform establishes a foundation for chronic multimodal neuromodulation, supporting long-term circuit studies across distributed laboratories.